Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.209ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.209ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.209ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.209NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.236ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.236ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.236ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.236NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XQORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XQENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XQNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.59ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.59ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.59NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.395ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.395ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.395ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.395NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.120.2.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.120.2.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.120.2.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.120.2.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.416.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.416.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.416.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.416.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.532ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.532ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.532ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.532NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.408ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.408ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.408ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.408NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XHORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XHNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.168ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.423ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used